explore -WSS

explore

author：hotspot 2025-10-02 02:30:37 - browse：1648

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Flu vaccine reformulation won't be easy, manufacturers warn

focus

WSS

Group behind ProMed defends move to subscription

FDA sets aggressive timeline for overhauling inspection procedures

Head of FDA's diagnostics center, who led through Covid, retires

Dana Farber says 6 studies to be retracted and 31 corrected

Update the Apgar Score to remove skin color

CVS is on a mission to consolidate health care. Will it work?

focus

explore

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Florida officials tell state schools to teach AP Psychology 'in its entirety'

In Memoriam: Notable people who died in 2023

Medicare slashes safety net hospital payments by nearly $1 billion

Hepatitis C has a cure — but many Americans still lack access to it

Heart disease in astronauts blamed on cosmic radiation

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA scientists endorse Pfizer/BioNTech Covid

Dobbs anniversary: the lost opportunity of abortion as health care

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Wikipedia

The cancer stories no one wants to hear

A pediatrician calls for Congress to pass the child tax credit deal

There's an unseen cost to disruptive road

Microsoft launches AI tool for clinical documentation through Epic

Printout prescription drug information shouldn’t go digital

FDA approves Sage Therapeutics’ rapid

hotspot

hotspot

focus

focus